Name of Student: Rene John G.

Francisco Name of Patient: Villegas, Freddie

Year, Section, and Group: BN4-A; Group 2 Sex: Male

Date: January 30, 2013

Age: 70 years old

Chief Complaints: Left Lateral Neck Mass

Final Diagnosis: Lateral Neck Mass probably Malignant Drug Study (Potassium Chloride)

Name

Generic Name: Potassium Chloride Trade name: Kalium Durule Classification: Electrolytes Sources: o Nursing 2007 Drug Handbook 27th Edition, Lippincot Williams & Wilkins o Nurseslabs.com Kalium Durule (Potassium Chloride) Drug Study http:// nurseslabs.com/kali um-durulepotassium-chloridedrug-study/#_

Dosage/ Route/Freq uency Dosage: 10 mEq x 20 cycles (IV solution)

Mechanism of Action Principal intracellular cation of most body tissues, participates in a number of physiology process maintaining intracellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, maintenance of normal renal function; also plays a role in carbohydrate metabolism and various enzymatic reactions

Indication

Contraindications

Adverse Reactions CV: Arrhythmias, Heart block, Hypotension, Cardiac arrest, Hyperkalemia, Respiratory: Respiratory paralysis Dermatologic: Rash GI: Nausea, vomiting, diarrhea, abdominal discomfort, GI obstruction, GI bleeding, GI ulceration or perforation Hematologic: Hyperkalemiaincreased serum K+, EFG changes (peaking of T waves, loss of P wavs, depression of ST segment, prolongation of QT interval) Local: Tissue sloughing, local necrosis, local phlebitis, and venospasm with injection

Nursing Responsibilities

Prevention and correction of potassium deficiency

Frequency: IV solution administere d as a continuous IV infusion

Route: IVTT

Contraindicated with allergy to tartrazine, aspirin (tartrazine is found in some preparations marketed as Kaon-Cl, Klor-Con); severe renal impairment with oliguria, anuria, azotemia; untreated Addisons disease; hyperkalemia; adynamia episodica hereditaria; acute dehydration; heat cramps; GI disorders that delay passage in the GI tract. Use cautiously with cardiac disorders, especially if treated with digitalis

Assessment History: Allergy to tartrazine, aspirin; severe renal impairment; untreated Addisons disease; hyperkalemia; adynamia episodica hereditaria; acute dehydration; heat cramps, GI disorders that cause delay in passage in the GI tract, cardiac disorders, lactation Physical: Skin color, lesions, turgor; injection sites; P, baseline ECG; bowel sounds, abdominal examination; urinary output; serum electrolytes, serum bicarbonate Interventions Arrange for serial potassium levels before and during therapy Caution patient that expanded wax matrix capsules will be found in the stool Report tingling of the hands or feet, unusual tiredness or weakness, feeling of heaviness in the legs, severe nausea, and vomiting, abdominal pain, black or tarry stools. Monitor cardiac rhythm carefully during IV administration